Pathway Medical Receives 510(k) Clearance for Jetstream G3 Atherectomy System

Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral vascular disease (PVD), Wednesday announced that the U.S. Food & Drug Administration has granted the company 510(k) clearance to market JETSTREAM G3, its newest peripheral revascularization catheter for the treatment of PVD.
Earth Times